
Dr. Walter M Stadler MD
Hematologist-Oncologist | Hematology & Oncology
5841 S Maryland Ave Mc 2115 Chicago IL, 60637About
Dr. Walter Stadler is a hematologist oncologist practicing in Chicago, IL. Dr. Stadler specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Yale Univ Sch of Med, New Haven Ct 1988
Yale School of Medicine 1988
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer.
- In vitro evaluation of calphostin C as a novel agent for photodynamic therapy of bladder cancer.
- Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17.
- Granulocyte-macrophage-colony stimulating factor in combination immunotherapy for
- Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer.
- Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4.
- A G2/M growth arrest response to low-dose intermittent H2O2 in normal uroepithelial cells.
- Angiogenesis inhibitors.
- Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers.
- Treatment of metastatic urothelial cancer in the post-MVAC era.
- Clinical trial designs for cytostatic agents.
- Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization.
- A phase II trial of weekly intravenous gemcitabine and cisplatin with continuous infusion fluorouracil in patients with metastatic renal cell carcinoma.
- Gemcitabine doublets in advanced urothelial cancer.
- Flt-3 ligand and sequential FL/interleukin-2 in patients with metastatic renal carcinoma: clinical and biologic activity.
Clinical Trials
Treatments
- Prostate Cancer
- Bladder Cancer
- Kidney Cancer
- Testicular Cancer
- Extra Corporeal Shockwave Therapy
Fellowships
- University Of Health Sciences/Chicago Medical School
Dr. Walter M Stadler MD's Practice location
Practice At 5841 S Maryland Ave Mc 2115
5841 S Maryland Ave Mc 2115 -Chicago, IL 60637Get Direction
Dr. Walter M Stadler MD's reviews
Write ReviewPatient Experience with Dr. Stadler
Recommended Articles
- Teen with Hodgkin Lymphoma Skates with Her Hero, Mario Lemieux
Lillian Tarasiewicz was diagnosed with stage 3B Hodgkin lymphoma in October of 2015. She currently resides in South Carolina, but because of her father’s Pennsylvania background, she grew up with a love for hockey and for the Pittsburgh Penguins. She always felt a special connection to Mario...
- Survey Shows Lack of Blood Cancer Knowledge Among Americans
If anyone is asked to describe what cancer is, chances are they’ll be able to provide at least a rough definition of the disease. Generally speaking, cancer is the name for the rapid and uncontrollable development of cells in a certain part of the body. In addition to holding a general awareness...
- New Study Discovers How Lymphoma Affects Survivors’ Ability to Work
Young adults in many countries pride themselves on their work. They have worked hard to get to where they are and there is a huge sense of accomplishment in joining the adult world and being able to provide for themselves and their new families if applicable. When cancer comes along, their ability...
- Overcoming Lymphoma: A South Philly Student's Story
In April of 2018, 18-year-old Alexis Carine was diagnosed with Hodgkin’s lymphoma (HL), a blood cancer that begins in the lymphatic system. Her diagnosis was stage II HL, a cancer found in two or more lymph node areas, and both are either above or below the diaphragm (the muscle located just...
- Facts About Multiple Myeloma
Multiple myeloma is a certain form of cancer of the plasma cell, which is part of the immune system. It initiates in the bone marrow, where the blood cells are produced.The immune system is made of variety of cells that fight infections and keep the body healthy. What takes place in bone marrow...
- The Promising Future of Gene Therapy and Lymphoma
Non-Hodgkin lymphoma affects over 700,000 people in America alone. Though current treatments are moderately effective, especially for aggressive forms of the disease, more can be done to help people impacted by NHL. Researchers are doing just that by working to develop new, innovative treatment for...
Nearby Providers
- Dr. Akash Patnaik M.D., PH.D.5841 S MARYLAND AVE CHICAGO IL 60637
- Dr. Justin Paul Kline M.D.5841 S Maryland Ave Chicago IL 60637
- Dr. Andrew Saul Artz M.D., M.S.5841 S Maryland Ave Chicago IL 60637
- Dr. Michael J. Thirman M.D.5841 S Maryland Ave Chicago IL 60637
- Dr. Sunil Narula MD5841 S MARYLAND AVE CHICAGO IL 60637
- Dr. Elias I Obeid M.D., MPH5841 S Maryland Ave Chicago IL 60637
Nearest Hospitals
PROVIDENT HOSPITAL OF CHICAGOl
500 E 51ST ST CHICAGO IL 60615